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Abstract 
Background: Neonatal mortality rates are much higher in the developing world than in 
developed countries.  Infections are a major cause for neonatal death, particularly in preterm 
infants where a defective epidermal permeability barrier function facilitates transcutaneous 
pathogen invasion. Objectives: To determine whether neonatal skin care products, commonly 
used in Africa, benefit or compromise epidermal functions in murine skin. Methods: Following 
the twice daily treatment of 6-8 weeks old hairless mice with each skin care product for 3 days, 
epidermal permeability barrier function, skin surface pH, stratum corneum hydration and barrier 
recovery were measured with an MPA5 physiology monitor. For products showing some 
benefits in these initial tests, the epidermal permeability barrier homeostasis was assessed 1 and 
5 hours after a single application to acutely disrupted skin. Results: All of the skin care products 
compromised both basal permeability barrier function and barrier repair kinetics. Moreover, after 
3-day treatments, most of the products also reduced stratum corneum hydration, while also 
elevating skin surface pH to abnormal levels. Conclusions: These results demonstrate that some 
neonatal skin care products that are widely used in Africa perturb key epidermal functions, 
including permeability barrier homeostasis in mice. Should these products display 
 similar effects on newborn human skin, they could cause a defective epidermal permeability 
barrier, which can increase body fluid loss, impair thermoregulation, and contribute to the high 
rates of neonatal morbidity and mortality that occur in Africa. Accordingly, alternative products 
that enhance permeability barrier function should be identified, particularly for use in preterm 
infants. 
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Introduction 
Mortality rates are declining year by year worldwide [1], but neonatal mortality rates still exceed 
4% in the developing world, accounting for 44% of all under-5 deaths [2]. Among contributors 
to neonatal mortality, prematurity, low birth weight, and perinatal infections are the leading 
causes[3,4]. Mortality rates for pre-term (<37 weeks gestational age) and low birth weight 
infants (<2500g) are higher than for their full- term and normal normal-birth birth-weight 
counterparts [5-7].  Sixty to 80% of all neonatal deaths link to low birthweights [8], and preterm 
birth-associated complications are the leading cause of neonatal deaths in world -wide [9].  
Preterm birth rates are particular high in Africa and Southeast Asia, ranging from 15-18%, and 
the overall neonatal mortality rate is as high as 4.7% [5,10]. Given the magnitude of the problem, 
the need to identify approaches that reduce neonatal mortality rates in the developing world, 
especially for pre-term and low birth weight infants is well recognized [11]. 
Skin plays an important role in preventing infections [12], but even full-term neonatal skin is not 
fully functional, which may increase the risk of infections and inflammatory dermatosees. Full-
term neonatal epidermis exhibits elevated transepidermal water loss (TEWL) rates, reduced 
stratum corneum (SC) hydration from low natural moisturizer content, and an elevated skin 
surface pH [13-15]. These abnormalities are further intensified in premature infants, who have a 
TEWL over 10-fold higher than their full-term counterparts, and they require a longer time to 
develop a mature permeability barrier than full-term infants [16-21].  
Immature epidermal function in preterm infants may contribute to neonatal morbidity and 
mortality in several ways. First, a compromised permeability barrier and an elevated skin surface 
pH promote colonization by Staphylococcus aureus and other microbial pathogens, in addition to 
4 
 
an increase in bacterial invasion, even by non-pathogenic ‘normal’ flora [22-24]. Second, a 
defective permeability barrier can allow excessive fluid loss and cause an imbalance of serum 
electrolytes [15,25]. Third, elevated TEWL rates are associated with higher rates of energy 
consumption and loss of body weight [26,27]. Previous trials have shown that topical 
applications of permeability barrier enhancing emollients can reduce neonatal mortality among 
preterm infants by decreasing infection rates and increasing body weights [28-32]. Despite these 
promising results, the range of emollients that are applied to babies in the home is extensive, but 
we know little about which of these products enhance barrier function. The trials show a 
mortality reduction when either sunflower oil, Aquaphor or coconut oil were applied [28], but 
there is evidence from mouse models that mustard oil, commonly used to massage neonates 
across South East Asia, may be harmful to the skin [33]. In Africa, emollient use in newborns is 
very common, with a wide range of emollients used, including cow butter, shea butter, coconut 
oil as well as commercial baby oils and lotions [34]. Given their wide use, whether these 
emollients provide important benefits, or conversely whether they are potentially harmful is not 
known. In this study, we assessed the impact of several widely used emollients widely used in 
three African countries on epidermal function in mousee models.  
Materials and Methods      
Materials: Previous studies have demonstrated that albino hairless (Skh1) mice represent a 
suitable animal model for assessing the potential impact of skin care products on cutaneous 
structure and function in humans. For example, mouse epidermis comprises three cell layers [35], 
while preterm neonatal human epidermis displays a comparable number of nucleated cell layers 
[36]. Moreover, several studies have shown that topical products that enhance barrier function in 
murine skin, predict parallel results in normal human skin [e.g., 37].  Therefore, we used the 
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widely-accepted hairless mouse model in the present study. Six-to-eight-week-old 6-8 weeks old 
female SKH1 mice were purchased from Charles River Laboratories (Wilmington, MA). The 
emollients tested came from four African sites that were part of a pilot research study on local 
emollient use in Ekiti State in South West Nigeria, Borno State in North East Nigeria, the 
Oromia region of Ethiopia, and the Lindi and Mtwara regions of Tanzania. The sites and the 
formative research are described elsewhere [33]. Emollients were selected for testing because 
they are commonly used in the sites, but were of unknown benefit or harm.  The exact 
ingredients in all products were unknown.  The emollients tested included both manufactured 
and homemade butters, oils and lotions. Manufactured emollients were collected for testing from 
an unopened bottle purchased from a reputable shop in or close to the study sites, and home-
made emollients were collected and stored as soon after production as possible.    
Samples were collected in clear glass bottles that were filled to the top to reduce the potential for 
oxidation. Immediately after collection, s amples were stored in the refrigerator and airfreighted 
with ice packs in insulated boxes to the University of California, San Francisco for analysis as 
described in the methods section below.  If a similar emollient was commonly used in more than 
one site, then samples were taken from both sites as chemical composition can vary. In total two 
emollients were tested from Ethiopia (E): locally manufactured Vaseline
TM
 (a Unilever 
trademarktm ofbrand petroleum jelly) and cow butter. Five from Borno State, Nigeria (B) were 
tested: shea butter, baby oil , olive oil , groundnut oOil  and neem oil . Three from Ekiti State, 
Nigeria (EK) were tested:  shea butter, baby lotion and olive oil. Five products from Lindi and 
Mtwara districts in Tanzania (T) were tested:  Two types of cooking oil, two types of coconut oil 
and baby oil. Emollients were made between September, 2010 and January, 2012, and collected 
by the fieldworkers between December, 2011 and February, 2012, and analyzed between 
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February and May, 2012.  
Experimental protocols and functional studies: All animal procedures were approved by the 
Animal Studies Subcommittee (IACUC) of the San Francisco Veterans Administration Medical 
Center and performed in accordance with their guidelines. Experiments were carried out in a 
temperature and humidity controlled room. The temperature was 70 ± 2oF≈approximately 
21±10C and humidity ranged from 46% to 48%. Both flanks of 10 mice were topically treated 
with individual emollients twice daily for three days. Butters were warmed to 45 0C before 
application; all other emollients were deployed at room temperature. Two to three products were 
tested alongside a control group of 10 untreated mice on each day. 
 Two to three products were tested on each day, and in the meanwhile, an additional group of 
uUntreated mice served as normal controls. Epidermal functions were assessed as described 
previously [38,39].  Briefly, basal epidermal biophysical properties were assessed by measuring 
transepidermal water loss (TEWL) using a TM300 connected to MPA5 (C&K, Cologne, 
Germany).  For barrier recovery, changes in TEWL levels were measured at immediately after (0 
time point) and three hours after tape stripping, which resulted in an ≈approximately 10-fold 
increase in TEWL, and percent barrier recovery rates were calculated. The results were 
normalized to levels in untreated controls, setting the untreated controls as 100%. For products 
showing some potential benefits in the initial tests or in previous studies, the effects of single 
application of individual emollients on barrier homeostasis in barrier-damaged mouse skin was 
determined. Products were applied topically immediately after barrier disruption in normal 
hairless mice. Untreated tape-stripped mice served as controls. TEWL was measured at 0, 1 and 
5 hours after tape stripping. 
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Statistical Analyses: Data are expressed as mean ± SEM.  One-way ANOVA with Dunnett's 
Multiple Comparison Test was used to determine significant differences between treated and 
untreated groups.   
Results 
Impact of African Emollients on Basal Barrier Function and Permeability Barrier 
Homeostasis 
After three days of topical applications of each emollient to the flanks of separate cohorts of 
mice, no differences were observed in the overall macroscopic appearance of mouse skin, 
activity, or body weights between treated and untreated mice. As seen in Fig 1a, following 3 
days of applications, most of the products significantly increased basal TEWL levels with the 
exception of baby lotion (EK) and olive oil (EK). Vaseline
TM
 and cow butter (E), neem oil (B), 
coconut oil and baby oil (T) all provoked an over 3-fold increase in basal TEWL levels. Yet, 
supposedly similar products from different sites provoked variable responses.  For example, 
olive oil from Borno (B) provoked a nearly 2- fold increase in basal TEWL, but olive oil (EK) 
did not change basal TEWL. These results demonstrate first, that most of the skin care products 
tested here disturb the basal permeability barrier; ,  and second, that the impact of supposedly 
comparable skin care products can vary with their sources.  
Because barrier recovery kinetics is a more accurate predictor of cutaneous function, we next 
determined whether these products impact permeability barrier repair kinetics following 3 days 
of treatments. As seen in Fig 1b, most of the products delayed barrier recovery in comparison to 
untreated controls. Ground nut oil (B), olive oil (EK) and both coconut oils (T) had a particularly 
negative impact.  Yet, certain products, including VaselineTM  (E), shea butter (B and EK), and 
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both cooking oils (T), while dramatically increasing basal TEWL (Fig 1a), did not impair barrier 
recovery kinetics in comparison to untreated controls (Fig 1b). Olive oil (EK), while causing no 
dramatic changes in basal TEWL, significantly delayed barrier recovery in comparison with 
untreated skin. Notably, baby lotion (EK) altered neither basal barrier function nor barrier repair 
kinetics. These results indicate that certain skin care products used in Africa diversely affect 
basal barrier and barrier repair kinetics.  
Because previous studies showed that topical VaselineTM improves barrier function in acutely 
disrupted murine skin [40,41], and because we found that baby lotion (EK) did not significantly 
affect either basal TEWL or barrier repair kinetics, we next assessed the influence of these 
products on barrier function in barrier damaged skin. As seen in Fig 1c, baby lotion (EK) did not 
significantly improve barrier function both 1 and 5 hours after single application. However, 
Vaseline
TM
 (E) significantly improved TEWL 1 hour after a single application, but the benefits 
of Vaseline
TM
 were not sustained at 5 hours after application. 
Influences of Topical Skin Care Products on Skin Surface pH and Stratum Corneum 
Hydration 
Previous studies from our group have demonstrated that both the formation and the maintenance 
of a competent permeability barrier require an acidic SC pH [42-44].  Since most of the products 
tested here compromised basal permeability barrier function and barrier repair kinetics, we next 
assessed whether these products also change skin surface pH. Indeed, all of products 
significantly elevated skin surface pH following 3 days of topical applications, with the 
exception of baby lotion (EK) and olive oil (EK) (Fig 2a).  
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Because most products increase basal TEWL (Fig 1a), and changes in TEWL correlate with SC 
hydration [13], we next measured SC hydration following 3 days of treatment. VaselineTM (E) 
did not change SC hydration (Fig 2b), but both baby lotion (B) and baby oil (EK) elevated SC 
hydration, while the other tested products lowered SC hydration (Fig 2b).  
Discussion 
Previous studies have shown that improving the epidermal permeability barrier by topical 
emollients can reduce neonatal mortality rates in preterm infants [45,46]. Whether commonly 
used, locally available and inexpensive skin care products improve permeability barrier is barely 
known, particularly in Africa where the neonatal mortality rates are high [10]. In the present 
study, we show that the majority of the products commonly used in four study sites do not 
improve the permeability barrier in mice; instead, they compromise the barrier function in intact 
skin. The products that were particularly harmful were cow butter (E), groundnut oil, neem oil 
(B), coconut oil and baby oil (T). The results from these mouse studies suggest that most 
currently used emollients could conceivably have a harm the cutaneous permeability barrier of 
newborn humans; and consequently, they could contribute to neonatal mortality because of the 
central role of the permeability barrier in preventing infections.  Previous studies have shown 
that perturbed permeability barrier not only facilitates microbial invasion [22,47,48], a major 
cause for neonatal death[48,49], but also predisposes to the development of dermatitis [48,50]. 
Skin surface pH is already higher than normal in neonates [13,42,51], and the negative impact of 
these products on SC pH could not only further compromise the permeability barrier [44,52], but 
also favor microbial infections [22,24]. The potential negative impact of these products may be 
exacerbated in some settings by the way that these products are applied, which has been found to 
be forceful [34]. Only baby lotion (EK) showed some benefit in the mouse models, as it 
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increased SC hydration without altering skin surface pH, TEWL or barrier recovery. Vaseline
TM
 
from Ethiopia (E) did not alter SC hydration or barrier recovery, but did increase basal TEWL 
and minimally increased skin surface pH.  However, it did benefit mice with defective 
permeability barriers, suggesting that Vaseline
TM
  could benefit preterm neonates with defective 
permeability barriers.  However, the impact of VaselineTM was short-term, which supports prior 
studies that have shown that Vaseline
TM
 exerts only short-term benefits for barrier-damaged skin 
[40,41]. Hence, frequent application would be required for this product to provide maximum 
benefit.  
It is worth noting that certain products diversely impact epidermal functions. For example, Baby 
oil (B) significantly increased SC hydration (beneficialt), while dramatically damaging other 
epidermal functions, including increased basal TEWL and skin surface pH, and delayed barrier 
recovery.  Olive oil (EK) did not significantly alter basal TEWL or skin surface pH, but induced 
a dramatic reduction in SC hydration and barrier recovery rate. Likewise, baby lotion (EK) 
significantly increased SC hydration without provoking significant alterations in basal TEWL, 
barrier recovery rate and skin surface pH. Although baby lotion (EK) benefits SC hydration 
while Vaseline
TM
 (E) improves permeability barrier recovery, further studies would be required 
to determine whether a combination of these two products could further benefit skin with 
compromised epidermal function. 
Nevertheless, given these findings, trials of alternative products that may enhance permeability 
barrier function in newbornsinfants, such as sunflower oil, should be undertaken in Africa, 
particularly in preterm infants. Given that we found that the effects of similar skin care products 
on permeability barrier homeostasis varied with their sources, possibly because small differences 
in composition, processing and/or storage could result in functional differences after applications 
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to the skin, any future trials should take careful note of the source, manufacturing details and 
storage of the emollients used.  
This study had some limitations. Moreover, it is worth noting that adult Adult mice were used in 
the present study. The, and the results may therefore not exactly reflect the influences of 
products on newborn mice or humans. Hence, further studies would be required to assess 
whether they also are harmful to neonatal human epidermis aAlthough these results strongly 
suggest a likely negative impact of the tested products on newborn skin, further studies would be 
required to assess whether they also are harmful to neonatal human epidermis. Moreover, 
although the present study tested products used in certain African regions, the benefits of any 
neonatal skin care products should be also validated before being put placed on the market in 
other countries.  
The variation in impact by source may explain why previous studies have found that coconut oil 
benefits newborn skin [2], while our study found it harmful to mouse skin. In Nigeria, another 
explanation for the varied findings is that counterfeiting of products has been identified as a 
problem [34].  
Conclusions 
Certain skin care products, which are widely used in neonatal care in Africa, are harmful to the 
function of murine skin. Although previous studies have demonstrated that the impact of topical 
products on human skin is consistent with those on mice, whether these products negatively 
influence human epidermal function remains unknown. These results further suggest that most 
currently used emollients likely have a harmful impact on the permeability barrier of newborns, 
which could result in increased body fluid loss, impaired thermoregulation, while also 
predisposing to perinatal infections. Hence, use of these potentially harmful skin care products 
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could explain, at least in part, the high rates of neonatal morbidity and mortality that occur in 
Africa. Accordingly, studies of alternative products that enhance permeability barrier function 
should be undertaken, particularly in preterm infants. 
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Figure Legends  
Figure 1. Effects of Topical Skin Care Products on Epidermal Permeability Barrier. Mice 
were treated as described in the materials and method section. Basal epidermal function was 
measured 18 hours after last application. Fig 1A depicts the influences of topical skin care 
products on basal transepidermal water loss (TEWL) after 3 days of treatment (N=20). TEWL 
was measured 16 hours after the last application. Fig 1B displays the effects of topical skin care 
products on permeability barrier homeostasis 3 hours after barrier disruption with repeated tape 
stripping (N=20). And Fig 1C shows the effects of topical skin care products on permeability 
barrier homeostasis 1 and 5 hours after a single application to barrier disrupted murine skin 
(N=10). Staistical sSignificances are indicated in the figures.  
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Figure 2. Effects of Topical Skin Care Products on Skin Surface pH and Stratum Corneum 
Hydration. After 3 days of treatments with respective skin care product, stratum corneum 
hydration and skin surface pH were measured with a CM825 probe connected to MPA5 (C&K, 
Cologne, Germany).  pH900 (C&K, Cologne, Germany) was used to measure skin surface pH. 
Results were normalized by untreated controls as shown by dotted lines. Statistical 
sSignificances are indicated in the figures. N=20 for all. 
